The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....

Promoter Below 50pctOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹10.38

prior close

₹10.25

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%-0.7% vs market

Pharmaceuticals peers, median of 165sector-0.6%-1.2% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.9

15m

+1.0

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8-1.1-0.7-0.6-1.2

Next day

+2.2+1.9+0.4+0.5+1.7

+3.6+3.7-0.1+0.9+2.7

+4.0+4.2-0.2+0.8+3.2

+1.0+5.4-4.4+1.0-0.0

+2.8+5.9-3.1+1.8+1.0

+5.8+7.6-1.9+2.5+3.3

15d

-1.6+7.7-9.3+6.2-7.8

-6.3+8.6-14.8+5.5-11.8

-14.6+10.5-25.2+6.3-21.0

+6.9+13.3-6.4+10.5-3.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Premier Fiscal Services Pvt. Ltd., a promoter of Gennex Laboratories, has pledged 25,00,000 equity shares (1.029% of total share capital) in favour of M/s. Vidya Tradecon Pvt. Ltd. on June 9, 2026. The pledge was created to secure a temporary business loan of Rs. 1.25 crore, with the shares valued at Rs. 2.5 crore (security cover ratio of 2.0x). After this pledge, total encumbered shares of the promoter stand at 1,25,00,000 shares (5.145% of total share capital). The promoter currently holds 5,30,38,000 shares, representing 21.831% of Gennex Laboratories. The pledge is set to expire on December 7, 2026.

Likely market impact

This is a routine pledge creation by the promoter to raise short-term business funding rather than a sign of distress. With only 5.145% of total share capital encumbered, the financial leverage risk for shareholders remains limited. Investors should monitor if more shares get pledged or if there are any signs of invocation.